Calliditas Therapeutics AB Liabilities Arising From Financing Activities
Calliditas Therapeutics AB had Liabilities Arising From Financing Activities of SEK 979.13 million as of 2023-12-31, per its 20-F filed 2024-04-24.
Discontinued › Notes
ifrs-full:LiabilitiesArisingFromFinancingActivities · last filed 2024-04-24
- 2023-12-31: Liabilities Arising From Financing Activities 979.13M SEK.
- 2022-12-31: Liabilities Arising From Financing Activities 739.20M SEK.
- 2021-12-31: Liabilities Arising From Financing Activities 222.81M SEK.
- 2020-12-31: Liabilities Arising From Financing Activities 4.79M SEK.
| Period end | Liabilities Arising From Financing Activities |
|---|---|
| 2023-12-31 | 979.13M SEK 20-F · filed 2024-04-24 |
| 2022-12-31 | 739.20M SEK 20-F · filed 2024-04-24 |
| 2021-12-31 | 222.81M SEK 20-F · filed 2024-04-24 |
| 2020-12-31 | 4.79M SEK 20-F · filed 2023-04-26 |
| 2019-12-31 | 6.07M SEK 20-F · filed 2022-04-27 |